- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Carcinoma, Neuroendocrine
Medical specialists from France tagged as investigators in clinical trials studying Carcinoma, Neuroendocrine
Total 32 results
-
Antoine ItalianoSeen in:
- Aquitaine, Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
- Bordeaux Cedex, Institut Bergonié
- Bordeaux, Bergonie Institute
- Bordeaux, Institut Bergonié
- Bordeaux, Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest
Trials:- NCT05009927 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT05440786 (Principal Investigator)
- NCT05269355 (Principal Investigator)
- NCT02834884 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT02029001 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT05920408 (Principal Investigator)
- NCT05999994 (Principal Investigator)
Conditions:- C-KIT Mutation;
- Metastatic Gastrointestinal Stromal Tumor (GIST);
- Advanced Gastrointestinal Stromal Tumor (GIST);
- Breast Cancer;
- Pancreatic Cancer;
- Non Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Papillary Thyroid Cancer;
- Other Solid Tumors With Evidence of Activating RET Alteration;
- Neoplasm Metastasis;
- Sarcoma, Ewing;
- Leiomyosarcoma;
- All Tumor Types;
- Non-Small Cell Lung Cancer;
- Any Solid Tumor;
- Malignant Solid Neoplasms;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Advanced Solid Tumours;
- Adolescent;
- Neoplasms;
- Child
-
Benjamin BesseSeen in:
- Val-de-Marne, Villejuif, Gustave Roussy
- Villejuif Cedex, Gustave Roussy
- Villejuif, IGR Gustave Roussy
Trials:- NCT04819100 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT04710628 (Principal Investigator)
- NCT03157128 (Principal Investigator)
Conditions:- Carcinoma, Non-Small-Cell Lung;
- Breast Cancer;
- Pancreatic Cancer;
- Non Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Papillary Thyroid Cancer;
- Other Solid Tumors With Evidence of Activating RET Alteration;
- Metastatic Thymic Carcinoma;
- Thymoma Type B3;
- Non-Small Cell Lung Cancer;
- Any Solid Tumor
-
Camille BuffetSeen in:
- PARIS- cedex 13, Hopital Pitie Salpetriere -Unité Thyroïde-Tumeurs Endocrines
Trials:- NCT04211337 (Principal Investigator)
Conditions: -
Christelle de la FouchardièreSeen in:
- Lyon, Centre Leon Bérard
- Rhône-Alpes, Lyon, Centre Leon Bérard
Trials:- NCT04187404 (Principal Investigator)
- NCT04211337 (Principal Investigator)
-
Christine DocaoSeen in:
- Lille, Hôpital C. HURIEZ
Trials:- NCT04211337 (Principal Investigator)
Conditions: -
Côme LEPAGE, MDSeen in:
- Dijon, CHU Dijon
Trials:- NCT04268121 (Principal Investigator)
- NCT04894123 (Principal Investigator)
-
David TOUGERON, MDSeen in:
- Poitiers, CHRU de Poitiers La Miletrie
- Poitiers, CHU Poitiers
Trials:- NCT04166604 (Principal Investigator)
- NCT05152147 (Principal Investigator)
- NCT04730544 (Principal Investigator)
- NCT05615818 (Principal Investigator)
- NCT04268121 (Principal Investigator)
- NCT04006262 (Principal Investigator)
- NCT05776342 (Principal Investigator)
Conditions:- Metastatic Colorectal Cancer;
- Gastroesophageal Adenocarcinoma;
- Esophageal Adenocarcinoma;
- Gastric Neoplasms;
- Colorectal Cancer Metastatic;
- MSI-H Colorectal Cancer;
- Biliary Tract Neoplasms;
- Neuroendocrine Carcinoma;
- Digestive Cancer;
- Localized Oesogastric Adenocarcimona;
- MSI and or dMMR;
- Pancreatic Adenocarcinoma
-
Denis SMITH, MDSeen in:
- Pessac, BORDEAUX - Hôpital Haut-Levêque
- Pessac, CHU Bordeaux - Hôpital Haut Lévêque
- Pessac, Hopital Haut Leveque
- Pessac, Hôpital Haut Lévêque CHU Bordeaux
Trials:- NCT04166604 (Principal Investigator)
- NCT04739202 (Principal Investigator)
- NCT04730544 (Principal Investigator)
- NCT04268121 (Principal Investigator)
-
Diego TosiSeen in:
- Montpellier Cedex 5, Institut du Cancer de Montpellier - Val d'Aurelle
Trials:- NCT03157128 (Principal Investigator)
-
Eric BAUDIN, MD, PhDSeen in:
- Val De Marne, Villejuif, Gustave Roussy
Trials:- NCT02230176 (Principal Investigator)
Conditions: -
Fabien CALCAGNO, MDSeen in:
- Besançon, CHU Jean Minjoz
- Besançon, CHU de Besançon
Trials:- NCT04268121 (Principal Investigator)
- NCT05096390 (Principal Investigator)
-
Hakim MahammediSeen in:
- Puy-de-Dôme, Clermont-Ferrand, Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne
Trials:- NCT04211337 (Principal Investigator)
Conditions: -
Jacques MedioniSeen in:
- Cedex 15, Paris, Hôpital Européen Georges Pompidou
- Paris, Hôpital Européen Georges Pompidou
Trials:- NCT05514054 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT05659563 (Principal Investigator)
-
Julien HadouxSeen in:
- Villejuif Cedex, Gustave Roussy
- Villejuif, Institut Gustave Roussy
Trials:- NCT04579679 (Principal Investigator)
- NCT04211337 (Principal Investigator)
-
Marie-Eve GarciaSeen in:
- Bouches-du-Rhône, Marseille, Assistance Publique Hôpitaux de Marseille - Hôpital Nord
Trials:- NCT04211337 (Principal Investigator)
Conditions: -
Michel Ducreux, MDSeen in:
- Villejuif, Institut Gustave Roussy
Trials:- NCT04268121 (Principal Investigator)
- NCT05983367 (Principal Investigator)
-
Mickaël BURGYSeen in:
- Strasbourg, Institut de cancérologie Strasbourg europe
Trials:- NCT04211337 (Principal Investigator)
- NCT05328024 (Principal Investigator)
Conditions: -
Olivia HENTIC, MDSeen in:
- Clichy, Hopital Beaujon
Trials:- NCT04348045 (Principal Investigator)
- NCT04268121 (Principal Investigator)
-
Olivier DUBREUIL, MDSeen in:
- Paris, Groupe Hospitalier Diaconesses Croix Saint Simon
- Paris, Groupe Hospitalier Diaconesses Croix Saint-Simon
Trials:- NCT05615818 (Principal Investigator)
- NCT04268121 (Principal Investigator)
Conditions: -
PASCALE TOMASINISeen in:
- Bouches-du-Rhône, Marseille, Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone
- Marseille Cedex 20, Assistance Publique Hôpitaux de Marseille - Hôpital Nord
- Marseille, AP-HM
- Marseille, APHM Hôpital de la Timone
Trials:- NCT04819100 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT03157128 (Principal Investigator)
-
Patrice RodienSeen in:
- Maine-et-Loire, Angers, Centre Hospitalier Universitaire d'Angers
Trials:- NCT04211337 (Principal Investigator)
Conditions: -
Patricia NICCOLI, MDSeen in:
- Marseille, Institut Paoli-Calmettes
Trials:- NCT04268121 (Principal Investigator)
Conditions: -
Pauline AFCHAIN, MDSeen in:
- Paris, Hopital Saint Antoine
Trials:- NCT04268121 (Principal Investigator)
Conditions: -
Philippe CassierSeen in:
- Lyon Cedex 08, Centre Leon Bérard
Trials:- NCT03157128 (Principal Investigator)
-
Romain CORIAT, MDSeen in:
- Paris, APHP - Hôpital Cochin
- Paris, Hôpital Cochin
Trials:- NCT04166604 (Principal Investigator)
- NCT03704480 (Principal Investigator)
- NCT05615818 (Principal Investigator)
- NCT04268121 (Principal Investigator)
- NCT02979483 (Principal Investigator)
- NCT01910610 (Principal Investigator)
-
Rosine GUIMBAUD, MDSeen in:
- Toulouse, CHU Toulouse
- Toulouse, CHU Toulouse - IUCT Rangueil -Larrey
Trials:- NCT04730544 (Principal Investigator)
- NCT04268121 (Principal Investigator)
- NCT04006262 (Principal Investigator)
-
Slimane ZerdoudSeen in:
- Toulouse cedex 9, Institut Claudius Regaud
Trials:- NCT04211337 (Principal Investigator)
Conditions: -
Stéphane BardetSeen in:
- Caen Cedex 5, Centre Francois Baclesse
Trials:- NCT04211337 (Principal Investigator)
Conditions: -
Sylvie ZanettaSeen in:
- Côte-d'Or, Dijon, Centre Georges François Leclerc
- Dijon Cedex, GSK Investigational Site
- Dijon, Centre Georges-Francois-Leclerc
Trials:- NCT04211337 (Principal Investigator)
- NCT03088059 (Principal Investigator)
- NCT06256588 (Principal Investigator)
-
Thomas WALTER, MDSeen in:
- Lyon, Hôpital Edouard Herriot
Trials:- NCT04268121 (Principal Investigator)
Conditions:
Clinical Trials on Carcinoma, Neuroendocrine
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Neuroendocrine Neoplasm | Metastatic Neuroendocrine Carcinoma | Metastatic Large Cell Neuroendocrine Carcinoma | Metastatic Small Cell Neuroendocrine CarcinomaUnited States, Canada
-
National Cancer Institute (NCI)RecruitingAdvanced Extrapulmonary Neuroendocrine Carcinoma | Metastatic Extrapulmonary Neuroendocrine Carcinoma | Recurrent Extrapulmonary Neuroendocrine Carcinoma | Unresectable Extrapulmonary Neuroendocrine CarcinomaUnited States
-
Roswell Park Cancer InstituteIpsenActive, not recruitingUnresectable Pancreatic Neuroendocrine Carcinoma | Locally Advanced Digestive System Neuroendocrine Carcinoma | Locally Advanced Pancreatic Neuroendocrine Carcinoma | Metastatic Digestive System Neuroendocrine Carcinoma | Metastatic Pancreatic Neuroendocrine Carcinoma | Refractory Digestive... and other conditionsUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCRecruitingNeuroendocrine Tumors | High Grade Neuroendocrine Carcinoma, Any Site | Well-Differentiated Neuroendocrine CarcinomaUnited States
-
AIO-Studien-gGmbHNovartis Pharmaceuticals; Assign Data Management and Biostatistics GmbHCompletedNeuroendocrine Carcinoma, Grade 3 | Poorly Differentiated Malignant Neuroendocrine Carcinoma | Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 | Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma]... and other conditionsGermany
-
Amr Mohamed MDNovatek PharmaceuticalsRecruitingNeuroendocrine Carcinoma | Gastroenteropancreatic Neuroendocrine Tumor | Gastroenteropancreatic Neuroendocrine Neoplasm | Mixed Neuroendocrine-Non Neuroendocrine NeoplasmUnited States
-
University of Michigan Rogel Cancer CenterRecruitingPancreatic Adenocarcinoma | Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Carcinoma | Adenosquamous Carcinoma | Gastrointestinal Neuroendocrine Tumor | Gastrointestinal Neuroendocrine Carcinoma | Neuroendocrine Prostate CarcinomaUnited States
-
Peking Union Medical College HospitalRecruitingGastrointestinal Neuroendocrine CarcinomaChina
-
Nanjing Leads Biolabs Co.,LtdRecruitingAdvanced Neuroendocrine CarcinomaChina
-
Tianjin Medical University Cancer Institute and...RecruitingGastric Neuroendocrine CarcinomaChina